
Startups & growth Analysis
DermiSense is developing a patch to sample biomarkers without a blood draw
DermiSense is developing a porous microneedle patch for selected biomarker tests and proposes selling disposable patches to testing organizations.

DermiSense develops a porous microneedle platform intended to collect interstitial fluid for biomarker analysis.
DermiSense is developing a microneedle patch that collects fluid from beneath the skin for biomarker analysis. It intends the platform to work with on-body sensors or off-body analytical tools.
A company presentation describes disposable patches as a proposed product for healthcare providers and research partners. DermiSense reports an initial human fluid-extraction demonstration.
Loading profile details…
Biotechnology Engineering · Business involvement
As of 2026-11-08
Loading recent changes…
Editorial profile by MoneyMakers. Sources reviewed .

Brand marks identify the organization. Logo from the official website.
CEO
John Strang is chief executive officer of DermiSense.
View personal profile